Clinical development of new treatments for diabetic macular oedema
- 1 May 2012
- journal article
- review article
- Published by Taylor & Francis in Clinical and Experimental Optometry
- Vol. 95 (3) , 297-305
Abstract
The benchmark treatment for diabetic macular oedema, the major cause of visual impairment in patients with diabetes mellitus, has traditionally been laser photocoagulation; however, as laser treatment does not always improve vision or even prevent further loss in many cases, several new pharmacotherapies that are injected into the vitreous for diabetic macular oedema have been successfully trialled over the past decade. Others are currently being evaluated. The two major classes of these drugs are steroids and vascular endothelial growth factor antagonists. In this article we briefly review the major clinical studies recently conducted in this field.Keywords
This publication has 72 references indexed in Scilit:
- Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)Diabetes Care, 2010
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2010
- Three-Year Follow-up of a Randomized Trial Comparing Focal/Grid Photocoagulation and Intravitreal Triamcinolone for Diabetic Macular EdemaArchives of Ophthalmology (1950), 2009
- A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular EdemaOphthalmology, 2008
- A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular EdemaOphthalmology, 2007
- Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular oedemaBritish Journal of Ophthalmology, 2007
- A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedemaBritish Journal of Ophthalmology, 2007
- A reference standard for the measurement of macular oedemaBritish Journal of Ophthalmology, 2006
- Decreasing efficacy of repeated intravitreal triamcinolone injections in diabetic macular oedemaBritish Journal of Ophthalmology, 2006
- Inhibitors of Ocular NeovascularizationJAMA, 2005